Frontiers
Browse
Table_3_Emerging roles of alternative RNA splicing in oral squamous cell carcinoma.docx (39.75 kB)

Table_3_Emerging roles of alternative RNA splicing in oral squamous cell carcinoma.docx

Download (39.75 kB)
dataset
posted on 2022-11-25, 04:55 authored by Miaomiao Liu, Jihua Guo, Rong Jia

Alternative RNA splicing (ARS) is an essential and tightly regulated cellular process of post-transcriptional regulation of pre-mRNA. It produces multiple isoforms and may encode proteins with different or even opposite functions. The dysregulated ARS of pre-mRNA contributes to the development of many cancer types, including oral squamous cell carcinoma (OSCC), and may serve as a biomarker for the diagnosis and prognosis of OSCC and an attractive therapeutic target. ARS is mainly regulated by splicing factors, whose expression is also often dysregulated in OSCC and involved in tumorigenesis. This review focuses on the expression and roles of splicing factors in OSCC, the alternative RNA splicing events associated with OSCC, and recent advances in therapeutic approaches that target ARS.

History